Scott M. Wasserman
Private Equity Investor chez Frazier Management LLC
Postes actifs de Scott M. Wasserman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01/10/2023 | - |
Historique de carrière de Scott M. Wasserman
Anciens postes connus de Scott M. Wasserman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Latigo Biotherapeutics, Inc.
 Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Directeur Général | 01/05/2019 | 01/06/2023 |
| AMGEN INC. | Private Equity Investor | 01/06/2005 | 01/05/2019 |
Formation de Scott M. Wasserman
| Haverford College | Undergraduate Degree |
| Harvard Medical School | Graduate Degree |
| Stanford University School of Medicine | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Private Equity Investor | 2 |
| Undergraduate Degree | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Health Technology |
- Bourse
- Insiders
- Scott M. Wasserman
- Expérience
